Stroke Prevention in Patients with Atrial Fibrillation.
作者信息
Kowey Peter R
出版信息
J Innov Card Rhythm Manag. 2018 Apr 15;9(4):3091-3092. doi: 10.19102/icrm.2018.090405. eCollection 2018 Apr.
Abstract
摘要
相似文献
1
Stroke Prevention in Patients with Atrial Fibrillation.心房颤动患者的卒中预防
J Innov Card Rhythm Manag. 2018 Apr 15;9(4):3091-3092. doi: 10.19102/icrm.2018.090405. eCollection 2018 Apr.
2
Global Prospective Safety Analysis of Rivaroxaban.全球利伐沙班安全性前瞻性分析
J Am Coll Cardiol. 2018 Jul 10;72(2):141-153. doi: 10.1016/j.jacc.2018.04.058.
3
Stroke Prevention in Atrial Fibrillation: Looking Forward.心房颤动的卒中预防：展望未来。
Circulation. 2020 Dec 15;142(24):2371-2388. doi: 10.1161/CIRCULATIONAHA.120.049768. Epub 2020 Dec 14.
4
5
XANTUS: rationale and design of a noninterventional study of rivaroxaban for the prevention of stroke in patients with atrial fibrillation.赞图斯：利伐沙班预防心房颤动患者中风的非干预性研究的原理与设计
Vasc Health Risk Manag. 2014 Jul 17;10:425-34. doi: 10.2147/VHRM.S63298. eCollection 2014.
6
Trends in utilization of antithrombotic therapy in patients with atrial fibrillation before stroke onset in a community-based study, from 1985 through 1997. From scientific evidence to practice.一项基于社区的研究中，1985年至1997年房颤患者在卒中发作前抗栓治疗的使用趋势。从科学证据到临床实践。
Prev Med. 2004 Feb;38(2):121-8. doi: 10.1016/j.ypmed.2003.09.002.
7
Transient ischemic attacks in patients with atrial fibrillation: implications for secondary prevention: the European Atrial Fibrillation Trial and Stroke Prevention in Atrial Fibrillation III trial.心房颤动患者的短暂性脑缺血发作：对二级预防的启示：欧洲心房颤动试验和心房颤动卒中预防III试验
Stroke. 2004 Apr;35(4):948-51. doi: 10.1161/01.STR.0000120741.34866.1D. Epub 2004 Feb 26.
8
Stroke prevention strategies in high-risk patients with atrial fibrillation.高危房颤患者的卒中预防策略。
Nat Rev Cardiol. 2021 Apr;18(4):276-290. doi: 10.1038/s41569-020-00459-3. Epub 2020 Oct 27.
9
Secondary prevention in non-valvular atrial fibrillation patients: a practical approach with edoxaban.非瓣膜性心房颤动患者的二级预防：依度沙班的实用方法
Int J Neurosci. 2017 Aug;127(8):716-725. doi: 10.1080/00207454.2016.1232256. Epub 2016 Sep 20.
10
Stroke Prevention in Nonvalvular Atrial Fibrillation: A Stakeholder Perspective.非瓣膜性心房颤动的卒中预防：利益相关者视角。
J Am Coll Cardiol. 2018 Jun 19;71(24):2790-2801. doi: 10.1016/j.jacc.2018.04.013.
本文引用的文献
1
Left Atrial Appendage Occlusion: What Are the Options and Where is the Evidence?左心耳封堵术：有哪些选择，证据何在？
J Innov Card Rhythm Manag. 2018 Apr 15;9(4):3095-3106. doi: 10.19102/icrm.2018.090402. eCollection 2018 Apr.
2
Tailored Anticoagulation for Thromboembolic Risk Reduction in Paroxysmal Atrial Fibrillation.个体化抗凝治疗以降低阵发性心房颤动的血栓栓塞风险
J Innov Card Rhythm Manag. 2018 Apr 15;9(4):3116-3125. doi: 10.19102/icrm.2018.090404. eCollection 2018 Apr.
3
Reversal Agents: What We Have and What We Can Expect.逆转剂：我们现有的和我们所能期待的。
J Innov Card Rhythm Manag. 2018 Apr 15;9(4):3108-3114. doi: 10.19102/icrm.2018.090403. eCollection 2018 Apr.
Zotero 插件